Panitumumab (pmab) in patients (pts) with chemorefractory metastatic colorectal cancer (mCRC): Final analysis from a community-based, observational study (VECTOR) in Germany

被引：2
|
作者：
Lerchenmuller, Christian A.
Groschek, Matthias
Kroening, Hendrik
Scheuer, Burkhard
Stauch, Martina
Kuhn, Anja
Hellebrand, Eva
Vehling-Kaiser, Ursula
机构：
[1] Schwerpunktpraxis Hamatol & Onkol, Magdeburg, Germany
[2] Onkolog Schwerpunktpraxis Kronach, Kronach, Germany
[3] Amgen GmbH, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.550
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
550
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety summary of panitumumab (pmab) in combination with chemotherapy (ctx) from four clinical trials in patients (pts) with metastatic colorectal cancer (mCRC)
    Price, T. J.
    Peeters, M.
    Douillard, J.
    Mitchell, E.
    Cohn, A.
    Strickland, A. H.
    Rivera, F.
    Xu, F.
    Gansert, J.
    Siena, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Updated analysis of a phase II study (20060314) of panitumumab (pmab) with FOLFIRI as first-line treatment of patients (pts) with metastatic colorectal cancer (mCRC)
    Greil, R.
    Letocha, H.
    Gamelin, E.
    Thaler, J.
    Hofheinz, R.
    Mineur, L.
    Fernebro, E.
    Karthaus, M.
    Wright, L.
    Koehne, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Panitumumab in chemorefractory patients with wild-type KRAS mCRC: First results from a community-based non-interventional cohort study (VECTOR) in Germany
    Groschek, M.
    Spohn, C.
    Kindler, M.
    Kroening, H.
    Scheuer, B.
    Stauch, M.
    Wiegand, J.
    Rieth, A.
    ONKOLOGIE, 2010, 33 : 175 - 175
  • [4] Panitumumab in Patients With Chemorefractory Wild-type KRas MCRC - Results of a Second Interim Analysis From a Community-based Non-interventional Cohort Study (VECTOR) in Germany
    Scheuer, B.
    Kroening, K.
    Lerchenmueller, C.
    Stauch, M.
    Boecher, E.
    Hellebrand, E.
    Kuhn, A.
    Groschek, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S438 - S438
  • [5] Panitumumab in chemorefractory patients with wild-type KRAS mCRC: Results of a second interim analysis from a community-based non-interventional cohort study (VECTOR) in Germany
    Groschek, M.
    Kroening, H.
    Lerchenmueller, C.
    Stauch, M.
    Bocher, E.
    Hellebrand, E.
    Kuhn, A.
    Scheuer, B.
    ONKOLOGIE, 2011, 34 : 221 - 221
  • [6] Patient-reported outcome (PRO)-assessed clinical benefit with panitumumab (Pmab) in metastatic colorectal cancer (mCRC) patients (pts)
    Hendlisz, A.
    Van Cutsem, E.
    Peeters, M.
    Humblet, Y.
    Neyns, B.
    Sobrero, A.
    Devercelli, G.
    Wolf, M.
    Amado, R. G.
    Siena, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Final STEPP results of prophylacatic versus reactive skin toxicity (ST) treatment (tx) for panitumumab (pmab)-related ST in patients (pts) with metastatic colorectal cancer (mCRC)
    Mitchell, E. P.
    Lacouture, M.
    Shearer, H.
    Iannotti, N.
    Piperdi, B.
    Pillai, M.
    Xu, F.
    Yassine, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)
  • [8] Final STEPP results of prophylacatic versus reactive skin toxicity (ST) treatment (tx) for panitumumab (pmab)-related ST in patients (pts) with metastatic colorectal cancer (mCRC)
    Mitchell, E. P.
    Lacouture, M.
    Shearer, H.
    Iannotti, N.
    Piperdi, B.
    Pillai, M.
    Xu, F.
    Yassine, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Final results from PRIME: Randomized phase III study of panitumumab (pmab) with FOLFOX4 for first line metastatic colorectal cancer (mCRC)
    Douillard, J.
    Siena, S.
    Cassidy, J.
    Tabernero, J.
    Burkes, R. L.
    Barugel, M. E.
    Humblet, Y.
    Cunningham, D.
    Xu, F.
    Krishnan, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Panitumumab (pmab) plus AMG 102 in patients (pts) with wild-type KRAS metastatic colorectal cancer (mCRC): Updated safety results
    Eng, C.
    Tabernero, J.
    Nowara, E.
    Swieboda-Sadlej, A.
    Tebbutt, N. C.
    Mitchell, E. P.
    Davidenko, I.
    Chen, L.
    Smethurst, D.
    Van Cutsem, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345